ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.932,17
-1,10%
S&P 500
5.021,89
-0,27%
Dow Jones
37.917,86
0,27%
Euro vs US Dollar
1,06815
0,14%
Bitcoin
57.070,33
-5,82%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AbSci Corporation (ABSI)

  7. AbSci Corporation (ABSI) News

ABSI AbSci Corporation

4,87
0,13 (2,74%)
Zuletzt aktualisiert: 17:11:49
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
AbSci Corporation ABSI NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,13 2,74% 4,87 17:11:49
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,86 4,805 5,09 4,74
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
16.4.202414:00GLOBEAbsci to Report Business Updates and First Quarter 2024..
28.3.202421:05GLOBEAbsci to Participate in the 23rd Annual Needham Virtual..
21.3.202412:30GLOBEAbsci Reports Business Updates and Fourth Quarter and Full..
01.3.202422:01GLOBEAbsci Announces Closing of Public Offering of Common Stock..
28.2.202422:06EDGAR2Form 8-K - Current report
28.2.202414:34EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28.2.202404:20GLOBEAbsci Announces Pricing of Public Offering of Common Stock
27.2.202422:45EDGAR2Form 8-K - Current report
27.2.202422:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27.2.202422:01GLOBEAbsci Announces Proposed Public Offering of Common Stock
21.2.202413:30GLOBEAbsci Initiates IND-Enabling Studies for ABS-101, a..
20.2.202414:00GLOBEAbsci to Participate in Upcoming Investor Conferences
14.2.202400:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06.2.202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202413:30GLOBEAbsci Appoints Professor Sir Mene Pangalos to its Board of..
08.1.202413:08EDGAR2Form 8-K - Current report
08.1.202413:00GLOBEAbsci to Present Preclinical Data for ABS-101, A Potential..
04.1.202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
03.1.202414:00GLOBEAbsci to Participate in the 26th Annual Needham Growth..
28.12.202314:00GLOBEAbsci to Participate in the 42nd Annual J.P. Morgan..
20.12.202314:30EDGAR2Form 8-K - Current report
20.12.202313:30GLOBEAbsci and PrecisionLife Announce Strategic R&D Partnership..
07.12.202314:30EDGAR2Form 8-K - Current report
04.12.202316:41DJNAbsci Shares Rise 27% After Announcing Collaboration With..
04.12.202313:31EDGAR2Form 8-K - Current report
04.12.202313:30GLOBEAbsci Announces Collaboration with AstraZeneca to Advance..
15.11.202314:00GLOBEAbsci to Participate in the Piper Sandler 35th Annual..
14.11.202322:40EDGAR2Form 8-K - Current report
14.11.202322:05GLOBEAbsci Reports Business Updates and Third Quarter 2023..
14.11.202308:16BWAlmirall and Absci announce AI drug discovery partnership to..
14.11.202308:05GLOBEAlmirall and Absci announce AI drug discovery partnership to..
26.10.202314:00GLOBEAbsci to Participate in Upcoming Investor Conferences
17.10.202300:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.10.202300:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.10.202300:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.10.202300:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.9.202314:00GLOBEAbsci Announces Speaker Lineup for Inaugural R&D Day,..
06.9.202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202314:00GLOBEAbsci to Host R&D Day on October 4, 2023
05.9.202314:15EDGAR2Form 8-K - Current report
28.8.202322:05GLOBEAbsci to Participate in Upcoming Investor Conferences
17.8.202323:02EDGAR2Form 8-K - Current report
14.8.202314:13EDGAR2Form 8-K - Current report
14.8.202314:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202314:02GLOBEAbsci Reports Business Updates and Second Quarter 2023..
14.8.202314:00GLOBEAbsci Appoints Zach Jonasson, Ph.D., as Chief Financial..

Kürzlich von Ihnen besucht

NASDAQ
ABSI
AbSci
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten